Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml.

Trial Profile

Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2015

At a glance

  • Drugs Maraviroc (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Proof of concept; Therapeutic Use
  • Acronyms VEMAN
  • Most Recent Events

    • 06 Mar 2013 Interim results reporting changes in CD4 cells and CD4 subsets presented at the 20th Conference on Retroviruses and Opportunistic Infections.
    • 28 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top